BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25962656)

  • 1. Incidences and outcomes of status epilepticus: A 9-year longitudinal national study.
    Tiamkao S; Pranboon S; Thepsuthammarat K; Sawanyawisuth K
    Epilepsy Behav; 2015 Aug; 49():135-7. PubMed ID: 25962656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A national database of incidence and treatment outcomes of status epilepticus in Thailand.
    Tiamkao S; Pranbul S; Sawanyawisuth K; Thepsuthammarat K;
    Int J Neurosci; 2014 Jun; 124(6):416-20. PubMed ID: 24102237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Status epilepticus in the elderly patients: A national data study in Thailand.
    Tiamkao S; Pranboon S; Thepsuthammarat K; Sawanyawisuth K
    J Neurol Sci; 2017 Jan; 372():501-505. PubMed ID: 27842985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes of death in patients with status epilepticus.
    Sirikarn P; Pattanittum P; Sawanyawisuth K; Tiamkao S
    Epilepsy Behav; 2019 Dec; 101(Pt B):106372. PubMed ID: 31300380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk score predictive of mortality in status epilepticus according to a national database.
    Tiamkao S; Buranakul N; Saybungkla P; Sirikarn P; Sawanyawisuth K;
    Epilepsia; 2018 Oct; 59 Suppl 2():182-187. PubMed ID: 30159871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of long-term mortality in status epilepticus.
    Tiamkao S; Saybungkla P; Sirikarn P; Sawanyawisuth K;
    Epilepsy Behav; 2018 Jul; 84():114-117. PubMed ID: 29778845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and mortality of super-refractory status epilepticus in adults.
    Kantanen AM; Reinikainen M; Parviainen I; Ruokonen E; Ala-Peijari M; Bäcklund T; Koskenkari J; Laitio R; Kälviäinen R
    Epilepsy Behav; 2015 Aug; 49():131-4. PubMed ID: 26141934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One- to 10-year Status Epilepticus Mortality (SEM) score after 30 days of hospital discharge: development and validation using competing risks analysis.
    Sirikarn P; Pattanittum P; Tiamkao S
    BMC Neurol; 2019 Dec; 19(1):307. PubMed ID: 31787084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between infections and clinical outcome parameters in status epilepticus: a retrospective 5-year cohort study.
    Sutter R; Tschudin-Sutter S; Grize L; Fuhr P; Bonten MJ; Widmer AF; Marsch S; Rüegg S
    Epilepsia; 2012 Sep; 53(9):1489-97. PubMed ID: 22812603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and outcome of patients with the ICU Admission diagnosis of status epilepticus in Australia and New Zealand.
    Hay A; Bellomo R; Pilcher D; Jackson G; Kaukonen KM; Bailey M
    J Crit Care; 2016 Aug; 34():146-53. PubMed ID: 27067289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status epilepticus associated with pregnancy: A cohort study.
    Lu YT; Hsu CW; Tsai WC; Cheng MY; Shih FY; Fu TY; Chuang YC; Tsai MH
    Epilepsy Behav; 2016 Jun; 59():92-7. PubMed ID: 27116537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperglycemia associated with seizure control in status epilepticus.
    Chiewthanakul P; Noppaklao P; Sawanyawisuth K; Tiamkao S
    Epilepsy Behav; 2015 Aug; 49():155-7. PubMed ID: 25982264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A one-year prospective study of refractory status epilepticus in Modena, Italy.
    Giovannini G; Monti G; Polisi MM; Mirandola L; Marudi A; Pinelli G; Valzania F; Girardis M; Nichelli PF; Meletti S
    Epilepsy Behav; 2015 Aug; 49():141-5. PubMed ID: 26074182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of status epilepticus in Srinagarind Hospital.
    Tiamkao S; Suko P; Mayurasakorn N;
    J Med Assoc Thai; 2010 Apr; 93(4):420-3. PubMed ID: 20462083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the Influence of Hospital Volume on Inpatient Outcomes Following Hospitalization for Status Epilepticus.
    Syed MJ; Zutshi D; Khawaja A; Basha MM; Marawar R
    Neurocrit Care; 2023 Feb; 38(1):26-34. PubMed ID: 36522515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with refractoriness and outcome in an adult status epilepticus cohort.
    Ulvin LB; Heuser K; Olsen KB; Taubøll E
    Seizure; 2018 Oct; 61():111-118. PubMed ID: 30125862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective observational study on hospital readmission for status epilepticus in the United States over 2016.
    Amengual-Gual M; Sánchez Fernández I; Vasquez A; Loddenkemper T
    Epilepsia; 2020 Jul; 61(7):1386-1396. PubMed ID: 32683696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from Germany.
    Kortland LM; Alfter A; Bähr O; Carl B; Dodel R; Freiman TM; Hubert K; Jahnke K; Knake S; von Podewils F; Reese JP; Runge U; Senft C; Steinmetz H; Rosenow F; Strzelczyk A
    Epilepsia; 2016 Dec; 57(12):2056-2066. PubMed ID: 27753082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of status epilepticus (SE): Effects of delayed treatment and SE duration.
    Santamarina E; Parejo B; Abraira L; Gutiérrez-Viedma Á; Alpuente A; Abarrategui B; Toledo M; Mazuela G; Salas-Puig X; Quintana M; García-Morales I
    Epilepsy Behav; 2018 Dec; 89():8-14. PubMed ID: 30384104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status epilepticus mimicking stroke recurrence.
    Pauletto G; Bax F; Gigli GL; Lorenzut S; Verriello L; Corazza E; Valente M
    Epilepsy Behav; 2020 Mar; 104(Pt B):106509. PubMed ID: 31629647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.